The risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis

Post Reprod Health. 2020 Sep;26(3):126-135. doi: 10.1177/2053369120956636.

Authors

Jo Marsden¹, Hugo Pedder²

Affiliations

¹ Medical Advisory Council, The British Menopause Society, UK.
² Statistical Modelling, University of Bristol, UK.

PMID: 32997592
DOI: 10.1177/2053369120956636

No abstract available

MeSH terms

Age Factors
Breast Neoplasms* / diagnosis
Breast Neoplasms* / epidemiology
Causality
Clinical Decision-Making / methods*
Clinical Trials as Topic
Consensus
Duration of Therapy
Estrogen Replacement Therapy* / adverse effects
Estrogen Replacement Therapy* / methods
Female
Humans
Middle Aged
Observational Studies as Topic
Risk Assessment* / methods
Risk Assessment* / statistics & numerical data
Risk Assessment* / trends